|
1
|
Liu X, Qian L, Nan HY, Cui M, Hao XY and
Du YF: Function of the transforming growth factor-β 1/c-Jun
N-terminal kinase signaling pathway in the action of thalidomide on
a rat model of pulmonary fibrosis. Exp Ther Med. 7:669–674.
2014.PubMed/NCBI
|
|
2
|
Moodley Y, Atienza D, Manuelpillai U,
Samuel CS, Tchongue J, Ilancheran S, Boyd R and Trounson A: Human
umbilical cord mesenchymal stem cells reduce fibrosis of
bleomycin-induced lung injury. Am J Pathol. 175:303–313. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Selman M, King TE and Pardo A: Idiopathic
pulmonary fibrosis: prevailing and evolving hypotheses about its
pathogenesis and implications for therapy. Ann Intern Med.
134:136–151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ortiz LA, Gambelli F, McBride C, Gaupp D,
Baddo M, Kaminski N and Phinney DG: Mesenchymal stem cell
engraftment in lung is enhanced in response to bleomycin exposure
and ameliorates its fibrotic effects. Proc Natl Acad Sci USA.
100:8407–8411. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang ZH, Lu Y, Luan Y and Zhao JJ: Effect
of bone marrow mesenchymal stem cells on experimental pulmonary
arterial hypertension. Exp Ther Med. 4:839–843. 2012.PubMed/NCBI
|
|
6
|
Kondo K, Shintani S, Shibata R, Murakami
H, Murakami R, Imaizumi M, Kitagawa Y and Murohara T: Implantation
of adipose-derived regenerative cells enhances ischemia-induced
angiogenesis. Arterioscler Thromb Vasc Biol. 29:61–66. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tzouvelekis A, Harokopos V, Paparountas T,
Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A,
Bouros D and Aidinis V: Comparative expression profiling in
pulmonary fibrosis suggests a role of hypoxia-inducible factor-1α
in disease pathogenesis. Am J Respir Crit Care Med. 176:1108–1119.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Z, Wang X, Yang R, Liu Y, Zhao W, Si J,
Ma X, Su C, Liu Y, Tan Y, Liu W, et al: Effects of carbon ion beam
irradiation on lung injury and pulmonary fibrosis in mice. Exp Ther
Med. 5:771–776. 2013.PubMed/NCBI
|
|
9
|
Sun YW, Li BP, Wang Xuan, Zhang L, Lu PY
and Zhao XY: Oriented migration of intravenously administrated
mesenchymal stem cells transfected with adenovirus vector mediated
green fluorescence protein in the lung tissue of pulmonary
emphysema rats. Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang
Kang Fu. 14:2528–2532. 2010.(In Chinese).
|
|
10
|
Cai Y: Pulmonary fibrosis drug treatment
progress. Shi Jie Lin Chuang Yao Wu. 29:17–19. 2008.(In
Chinese).
|
|
11
|
Liu T, Xie M, Wang HL and Ling W: Effect
of matrine and IFN-γ on bleomycin-induced pulmonary fibrosis.
Nanjing Yi Ke Da Xue Xue Bao. 28:592–596. 2008.(In Chinese).
|
|
12
|
Bhatt N, Baran C, Allen J, Magro C and
Marsh CB: Promising pharmacologic innovations in treating pulmonary
fibrosis. Curr Opin Pharmacol. 6:284–292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lettieri CJ, Veerappan GR, Helman DL,
Mulligan CR and Shorr AF: Outcomes and safety of surgical lung
biopsy for interstitial lung disease. Chest. 127:1600–1605. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu F: Research progress of Chinese
medicine treatment of pulmonary fibrosis. Yi Yao Dao Bao.
11:1471–1474. 2011.(In Chinese).
|
|
15
|
Xu L, Xiao W, Ma DD, Zhou SY and Zhang QH:
Ulcerative colitis combined with acute interstitial lung disease
and airway disease: A case report and literature review. Exp Ther
Med. 8:1229–1236. 2014.PubMed/NCBI
|
|
16
|
Kotton DN, Ma BY, Cardoso WV, Sanderson
EA, Summer RS, Williams MC and Fine A: Bone marrow-derived cells as
progenitors of lung alveolar epithelium. Development.
128:5181–5188. 2001.PubMed/NCBI
|
|
17
|
Krause DS, Theise ND, Collector MI,
Henegariu O, Hwang S, Gardner R, Neutzel S and Sharkis SJ:
Multi-organ, multi-lineage engraftment by a single bone
marrow-derived stem cell. Cell. 105:369–377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teke T, Maden E, Kiyici A, Korkmaz C, Gok
Z, Ozer F, Imecik O and Uzun K: Cigarette smoke and
bleomycin-induced pulmonary oxidative stress in rats. Exp Ther Med.
4:121–124. 2012.PubMed/NCBI
|
|
19
|
Tzouvelekis A, Antoniadis A and Bouros D:
Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med.
17:368–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui A, Dai HP and Dai JW: Effects of bone
marrow mesenchymal stem cells on bleomycin induced pulmonary
fibrosis in rats. Zhonghua Jie He He Hu Xi Za Zhi. 30:677–682.
2007.(In Chinese). PubMed/NCBI
|
|
21
|
Rojas M, Xu J, Woods CR, Spears W, Roman J
and Brigham KL: Bone marrow-derived mesenchymal stem cells in
repair of the injured lung. Am J Respir Cell Mol Biol. 33:145–152.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Beardmore VA, Ahonen LJ, Gorbsky GJ and
Kallio MJ: Survivin dynamics increases at centromeres during G2/M
phase transition and is regulated by microtubule-attachment and
Aurora B kinase activity. J Cell Sci. 117:4033–4042. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang M, Liu Y, Lu S, Wang Z, Wang R, Zi Y
and Li J: Analysis of the expression levels of surviving and VEGF
in patients with acute lymphoblastic leukemia. Exp Ther Med.
5:305–307. 2013.PubMed/NCBI
|
|
24
|
Liu F, Liu S, He S, Xie Z, Zu X and Jiang
Y: Survivin transcription is associated with P-glycoprotein/MDR1
over expression in the multidrug resistance of MCF-7 breast cancer
cells. Oncol Rep. 23:1469–1475. 2010.PubMed/NCBI
|
|
25
|
Chen Y, Ma N, Mei J, Xiao HB, Lu SW, Xu HY
and Zhong H: In vitro induction of human bone marrow
mesenchymal stem cells to differentiate into type II alveolar
epithelial cells. Zhong Guo Zu Zhi Gong Cheng Yan Jiu.
16:1737–1741. 2012.(In Chinese).
|
|
26
|
Guo T, Fang M, Zhang D and Li X:
Combination treatment with asiaticoside and repamycin: A new hope
for in-stent restenosis. Exp Ther Med. 6:557–561. 2013.PubMed/NCBI
|
|
27
|
Jiang PC, Xiong WP, Wang G, Ma C, Yao WQ,
Kendell SF, Mehling BM, Yuan XH and Wu DC: A clinical trial report
of autologous bone marrow-derived mesenchymal stem cell
transplantation in patients with spinal cord injury. Exp Ther Med.
6:140–146. 2013.PubMed/NCBI
|
|
28
|
Rubio D, Garcia S, Paz MF, De la Cueva T,
Lopez-Fernandez LA, Lloyd AC, Garcia-Castro J and Bernad A:
Molecular characterization of spontaneous mesenchymal stem cell
transformation. PLoS One. 3:e13982008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de la Fuente R, Bernad A, Garcia-Castro J,
Martin MC and Cigudosa JC: Retraction: Spontaneous human adult stem
cell transformation. Cancer Res. 70:66822010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin ZX and Xu H: Current understanding
into the biological characteristics of mesenchymal stem cells.
Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu.
15:3577–3580. 2011.(In Chinese).
|
|
31
|
Wang LZ, Xu L, Tan DM and Tan Y: The
progress of survivin. Yi Xue Zong Shu. 12:1089–1092. 2006.(In
Chinese).
|
|
32
|
Kobayashi M, Huang CL, Sonobe M, Kikuchi
R, Ishikawa M, Kitamura J, Miyahara R, Menju T, Iwakiri S, Itoi K,
Yasumizu R and Date H: Intratumoral Wnt2B expression affects tumor
proliferation and survival in malignant pleural mesothelioma
patients. Exp Ther Med. 3:952–958. 2012.PubMed/NCBI
|
